AUGIDACLA 60 MG 28 F.C. TABS

*DACLATASVIR IS A DRUG FOR THE TREATMENT OF HEPATITIS C (HCV). *DACLATASVIR INHIBITS THE HCV NONSTRUCTURAL PROTEIN NS5A. RECENT RESEARCH SUGGESTS THAT IT TARGETS TWO STEPS OF THE VIRAL REPLICATION PROCESS ENABLING RAPID DECLINE OF HCV RNA. *DACLATASVIR HAS BEEN TESTED IN COMBINATION REGIMENS WITH PEGYLATED INTERFERON AND RIBAVIRIN AS WELL AS WITH OTHER DIRECT-ACTING ANTIVIRAL AGENTS INCLUDING ASUNAPREVIR AND SOFOSBUVIR.